CCL20 and metabolic dysfunction-associated steatotic liver disease: During the progression of MASLD, mature adipocytes release chemokines, such as CCL20, and other soluble mediators, stimulating lymphocyte migration in adipose tissue through CCR6, resulting in obesity-related inflammation, such as insulin resistance, and the occurrence of MASLD (37).